Personalized statin therapy: Targeting metabolic processes to modulate the therapeutic and adverse effects of statins
Statins are widely used for treating lipid disorders and cardiovascular diseases. However, the therapeutic efficiency and adverse effects of statins vary among different patients, which numerous clinical and epidemiological studies have attributed to genetic polymorphisms in statin-metabolizing enzy...
Saved in:
Main Authors: | Zhuangqi Shi, Shuxin Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844025000088 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatotoxicity of statins: a real-world study based on the US Food and Drug Administration Adverse Event Reporting System database
by: Bojing Wang, et al.
Published: (2025-01-01) -
Statin use in resected, high-risk cutaneous melanoma: A multi-centre retrospective cohort study
by: Charlie Yue Wang, et al.
Published: (2024-12-01) -
Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”
by: Paul Y. Kwo
Published: (2024-10-01) -
When herpes zoster is not herpes: A case of statin-induced myopathy complicated by drug allergies
by: Hira Khalid Kareem, et al.
Published: (2025-01-01) -
β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers
by: Pedro Gabriel Senger Braga, et al.
Published: (2024-11-01)